{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:21:39Z","timestamp":1773710499860,"version":"3.50.1"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Adolescents with chronic disease engage in sexual activity similar to their healthy peers, with generally low utilization of contraception. Adolescents with rheumatic diseases prescribed teratogenic medications may be at risk for unplanned pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Using structured quality improvement (QI) methods with behavior economic (BE) principles, a multidisciplinary team aimed to implement pregnancy prevention processes for females on high-risk medications. We leveraged BE-inspired interventions including improved accessibility of consents, utilizing distinctly colored consent forms, real-time reminders, peer comparison, and audit and feedback. Our primary aim was to increase the number of days between pregnancies for postmenarcheal females followed in rheumatology clinics who were taking teratogenic medications. Phase 1 focused on annual consenting of female adolescents prescribed teratogenic drugs. Phase 2 emphasized sexual history screening and pregnancy prevention planning at every clinic visit for females \u226512 years on teratogenic medications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We increased the days between pregnancies for female adolescents prescribed teratogenic medications from 52 days to &amp;gt;900 days by using QI methodology with BE strategies. In phase 1, annual consents for postmenarcheal patients on teratogenic medications improved from 0% in 2017 to 95% in 2021. In phase 2, sexual history screening and pregnancy prevention planning at every clinic visit improved from 2% in 2019 to over 78% in 2021.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>A multiphase, multidisciplinary QI project with integration of behavior economic strategies can improve patient and caregiver counseling to prevent unplanned pregnancies for adolescents on teratogenic medications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2021-054294","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:16:16Z","timestamp":1670314576000},"source":"Crossref","is-referenced-by-count":3,"title":["Preventing Teen Pregnancies on Teratogenic Drugs by Quality Improvement and Behavioral Economics"],"prefix":"10.1542","volume":"151","author":[{"given":"Veronica M.","family":"Mruk","sequence":"first","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"*Contributed equally as co-first authors."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Wise","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"bPharmacy"},{"name":"*Contributed equally as co-first authors."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyla","family":"Driest","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Oberle","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy P.","family":"Ardoin","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagri","family":"Yildirim-Toruner","sequence":"additional","affiliation":[{"name":"cDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas"},{"name":"dDivision of Rheumatology, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Sivaraman","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Stevens","sequence":"additional","affiliation":[{"name":"ePsychology"},{"name":"fCenter of Clinical Excellence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec","family":"McGinnis","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"fCenter of Clinical Excellence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Gallup","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"fCenter of Clinical Excellence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brockton","family":"Mitchell","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"fCenter of Clinical Excellence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Lemle","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"},{"name":"fCenter of Clinical Excellence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jones","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Maher","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise D.","family":"Berlan","sequence":"additional","affiliation":[{"name":"gAdolescent Medicine, Department of Pediatrics, The Ohio State University and Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Barbar-Smiley","sequence":"additional","affiliation":[{"name":"aDivisions of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"issue":"11","key":"2023111013541983900_B1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjmed.2005.02.029","article-title":"Prescription of teratogenic medications in United States ambulatory practices","volume":"118","author":"Schwarz","year":"2005","journal-title":"Am J Med"},{"issue":"11","key":"2023111013541983900_B2","first-page":"713","article-title":"The new pregnancy and lactation labeling rule","volume":"41","author":"Pernia","year":"2016","journal-title":"P T"},{"issue":"6","key":"2023111013541983900_B3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-147-6-200709180-00006","article-title":"Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women","volume":"147","author":"Schwarz","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"2023111013541983900_B4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1454","article-title":"Contraceptive provision to adolescent females prescribed teratogenic medications","volume":"137","author":"Stancil","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"2023111013541983900_B5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/1054-139X(95)00282-W","article-title":"Sexual behavior of adolescents with chronic disease and disability","volume":"19","author":"Sur\u00eds","year":"1996","journal-title":"J Adolesc Health"},{"issue":"2","key":"2023111013541983900_B6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpag.2018.02.031","article-title":"Reproductive health risk counseling in adolescent and young adult women on methotrexate therapy for rheumatic diseases","volume":"31","author":"Berlan","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2023111013541983900_B7","unstructured":"Institute for Healthcare Improvement\n          . Quality improvement essentials toolkit. Available at: www.ihi.org\/resources\/Pages\/Tools\/Quality-Improvement- Essentials-Toolkit.aspx? Accessed February 26, 2021"},{"issue":"4","key":"2023111013541983900_B8","doi-asserted-by":"crossref","first-page":"e20180803","DOI":"10.1542\/peds.2018-0803","article-title":"Improving the safety of teratogen prescribing practices in a pediatric rheumatology clinic","volume":"143","author":"Cooper","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"2023111013541983900_B9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jmwh.12604","article-title":"An innovative framework to improve teratogenic medication risk counseling","volume":"62","author":"Shroff","year":"2017","journal-title":"J Midwifery Womens Health"},{"issue":"6","key":"2023111013541983900_B10","doi-asserted-by":"crossref","first-page":"e20160378","DOI":"10.1542\/peds.2016-0378","article-title":"Reliable pregnancy testing before intravenous cyclophosphamide: a quality improvement study","volume":"138","author":"Hayward","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"2023111013541983900_B11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.117.028380","article-title":"Leveraging behavioral economics to improve heart failure care and outcomes","volume":"136","author":"Chang","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"2023111013541983900_B12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.acap.2018.08.010","article-title":"Using behavioral economics to encourage parent behavior change: opportunities to improve clinical effectiveness","volume":"19","author":"Jenssen","year":"2019","journal-title":"Acad Pediatr"},{"issue":"2","key":"2023111013541983900_B13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/M15-1330","article-title":"Using behavioral economics to design physician incentives that deliver high-value care","volume":"164","author":"Emanuel","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"2023111013541983900_B14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/puar.12564","article-title":"The theory and practice of \u201cnudging\u201d: changing health behaviors","volume":"76","author":"Vlaev","year":"2016","journal-title":"Public Adm Rev"},{"issue":"1","key":"2023111013541983900_B15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0038-1641221","article-title":"Behavioral economics interventions in clinical decision support systems","volume":"27","author":"Cho","year":"2018","journal-title":"Yearb Med Inform"},{"issue":"6","key":"2023111013541983900_B16","first-page":"CD000259","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2023111013541983900_B17","unstructured":"Mycophenolate REMS\n          . Welcome to the mycophenolate REMS. Available at: https:\/\/www.mycophenolaterems.com\/#:\u223c:text=The%20Mycophenolate%20REMS %20is%20a%20program%20to%20tell, risk%20of%20miscarriage%20in%20 the%20first%203%20months. Accessed August 23, 2021"},{"key":"2023111013541983900_B18","unstructured":"ASQ\n          . About control chart. Available at: https:\/\/asq.org\/quality-resources\/control-chart. Accessed August 23, 2021"},{"issue":"5","key":"2023111013541983900_B19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023111013541983900_B20","first-page":"S80","article-title":"Use of methotrexate in young patients with respect to the reproductive system","volume":"28","author":"Gromnica-Ihle","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"2023111013541983900_B21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pds.5017","article-title":"Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: a retrospective cohort study","volume":"29","author":"Thai","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2023111013541983900_B22","doi-asserted-by":"crossref","first-page":"e20183141","DOI":"10.1542\/peds.2018-3141","article-title":"Previsit planning improves pneumococcal vaccination rates in childhood-onset SLE","volume":"145","author":"Sivaraman","year":"2020","journal-title":"Pediatrics"},{"issue":"1","key":"2023111013541983900_B23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u211063.w4361","article-title":"Improving clinical remission rates in pediatric inflammatory bowel disease with previsit planning","volume":"5","author":"Savarino","year":"2016","journal-title":"BMJ Qual Improv Rep"},{"issue":"5","key":"2023111013541983900_B24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpag.2020.05.011","article-title":"Implementation of pregnancy checklist into clinic workflow: a quality improvement initiative","volume":"33","author":"Dallaire","year":"2020","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"2023111013541983900_B25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13012-020-01072-1","article-title":"How effective are social norms interventions in changing the clinical behaviours of healthcare workers? A systematic review and meta-analysis","volume":"16","author":"Tang","year":"2021","journal-title":"Implement Sci"},{"issue":"1","key":"2023111013541983900_B26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13012-019-0883-5","article-title":"Clinical Performance Feedback Intervention Theory (CP-FIT): a new theory for designing, implementing, and evaluating feedback in health care based on a systematic review and meta-synthesis of qualitative research","volume":"14","author":"Brown","year":"2019","journal-title":"Implement Sci"},{"key":"2023111013541983900_B27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cca.2012.10.053","article-title":"Limitations in qualitative point of care hCG tests for detecting early pregnancy","volume":"415","author":"Greene","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2023111013541983900_B28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clinbiochem.2014.12.015","article-title":"Analytical sensitivity of four commonly used hCG point of care devices","volume":"48","author":"Kamer","year":"2015","journal-title":"Clin Biochem"},{"issue":"1-2","key":"2023111013541983900_B29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2009.05.018","article-title":"Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy","volume":"406","author":"Cervinski","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2023111013541983900_B30","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fpsyg.2020.01684","article-title":"The psychological impact of the COVID-19 outbreak on health professionals: a cross-sectional study","volume":"11","author":"Giusti","year":"2020","journal-title":"Front Psychol"},{"issue":"5","key":"2023111013541983900_B31","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.3390\/ijerph18052390","article-title":"From recession to depression? Prevalence and correlates of depression, anxiety, traumatic stress and burnout in healthcare workers during the COVID-19 pandemic in Greece: a multi-center, cross-sectional study","volume":"18","author":"Pappa","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"2023111013541983900_B32","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s11606-020-06529-z","article-title":"Impact of the early phase of the COVID-19 pandemic on US healthcare workers: results from the HERO registry","volume":"36","author":"Forrest","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"23","key":"2023111013541983900_B33","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1001\/jama.2020.7943","article-title":"Implications for telehealth in a postpandemic future: regulatory and privacy issues","volume":"323","author":"Shachar","year":"2020","journal-title":"JAMA"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054294\/1564369\/peds_2021054294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054294\/1564369\/peds_2021054294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T13:56:09Z","timestamp":1699624569000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/151\/1\/e2021054294\/190243\/Preventing-Teen-Pregnancies-on-Teratogenic-Drugs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,6]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-054294","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"e2021054294"}}